Altrafin AG’s Morgan Stanley MS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-15,200
Closed -$1.91M 47
2024
Q4
$1.91M Sell
15,200
-587
-4% -$72.3K 0.66% 32
2024
Q3
$1.65M Sell
15,787
-74
-0.5% -$7.45K 0.59% 34
2024
Q2
$1.54M Sell
15,861
-7,162
-31% -$682K 0.57% 37
2024
Q1
$2.17M Sell
23,023
-158
-0.7% -$13.9K 0.79% 35
2023
Q4
$2.16M Sell
23,181
-1,318
-5% -$105K 0.83% 35
2023
Q3
$2M Sell
24,499
-3,137
-11% -$272K 0.87% 36
2023
Q2
$2.36M Buy
27,636
+120
+0.4% +$10.3K 1.06% 31
2023
Q1
$2.42M Buy
27,516
+2,652
+11% +$247K 1.19% 29
2022
Q4
$2.11M Sell
24,864
-2,589
-9% -$221K 1.24% 28
2022
Q3
$2.17M Sell
27,453
-1,374
-5% -$116K 1.3% 27
2022
Q2
$2.19M Buy
28,827
+13,044
+83% +$1.07M 1.18% 29
2022
Q1
$1.38M Sell
15,783
-8,045
-34% -$776K 0.54% 43
2021
Q4
$2.34M Buy
+23,828
New +$2.37M 0.85% 38

Other funds holding MS

Altrafin AG's MS Position: Q1 2025 in Review

Altrafin AG sold out of Morgan Stanley (MS) in Q1 2025, closing a stake of 15,200 shares — an estimated $1.91M sold.

Altrafin AG first reported a position in MS in Q4 2021 and held it in 13 quarters. The position peaked at $2.42M in Q1 2023. 2,104 funds tracked by Wall St. Rank hold MS as of Q1 2025.

  • Altrafin AG reported no remaining Morgan Stanley position as of Q1 2025 after selling out during the quarter.
  • Altrafin AG sold 15,200 Morgan Stanley shares in Q1 2025, an estimated $1.91M.
  • Altrafin AG first reported a position in Morgan Stanley in Q4 2021 and held it in 13 quarters.
  • Altrafin AG's Morgan Stanley position peaked at $2.42M in Q1 2023.
  • 2,104 funds tracked by Wall St. Rank held Morgan Stanley as of Q1 2025.

Based on Altrafin AG's 13F filing for Q1 2025, filed 17 Feb 2026.